BIOCRYST PHARMACEUTICALS INC shareholders Q2 2023

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 236 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.

BIOCRYST PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
ExodusPoint Capital Management, LP 1,212,547$8,5360.07%
PROFUND ADVISORS LLC 176,892$1,245,3200.07%
Trexquant Investment LP 335,518$2,362,0470.06%
BNP Paribas Asset Management Holding S.A. 2,410,190$16,9680.05%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 232,463$1,636,5400.05%
GSA CAPITAL PARTNERS LLP 71,532$5040.05%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,155,723$8,136,2900.05%
NinePointTwo Capital LLC 17,174$1200.05%
PICTET ASSET MANAGEMENT SA 5,286,536$37,217,2130.04%
Rafferty Asset Management, LLC 974,963$6,863,7400.04%
Inspire Investing, LLC 44,583$313,8640.04%
Cypress Wealth Services, LLC 20,000$143,8000.04%
TWO SIGMA ADVISERS, LP 2,137,612$15,048,7880.04%
Dynamic Technology Lab Private Ltd 38,825$2730.03%
FRANKLIN STREET ADVISORS INC /NC 50,000$3520.03%
E Fund Management Co., Ltd. 52,423$3690.03%
Cubist Systematic Strategies, LLC 627,707$4,419,0560.03%
PANAGORA ASSET MANAGEMENT INC 685,509$4,825,9830.03%
Northeast Financial Consultants Inc 60,633$426,8570.03%
TWO SIGMA INVESTMENTS, LP 1,331,488$9,373,6760.02%
External links

This page lists BIOCRYST PHARMACEUTICALS INC's shareholders in Q2 2023. To view BIOCRYST PHARMACEUTICALS INC's shareholder history, click here.